These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 7699982

  • 21. [Experimental study on the antituberculous activity of ofloxacins].
    Duan L, Liang G, Li H.
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Apr; 20(2):98-100. PubMed ID: 10072834
    [Abstract] [Full Text] [Related]

  • 22. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW, Piddock LJ, Li MS, Lyon D, Chan CY, Cheng AF.
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [Abstract] [Full Text] [Related]

  • 23. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests].
    Yamamoto S, Toida I, Watanabe N, Ura T.
    Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227
    [Abstract] [Full Text] [Related]

  • 24. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
    Foroumadi A, Soltani F.
    Boll Chim Farm; 2003 Mar; 142(6):248-50. PubMed ID: 14606264
    [Abstract] [Full Text] [Related]

  • 25. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H, Lee KS, Ko YK, Ryu JW, Woo JC, Koo DW, Shin SJ, Ahn SJ, Shin AR, Song CH, Jo EK, Park JK, Kim HJ.
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [Abstract] [Full Text] [Related]

  • 26. Antimycobacterial drugs.
    Heifets LB.
    Semin Respir Infect; 1994 Jun; 9(2):84-103. PubMed ID: 7973175
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis].
    Kawahara S, Kamisaka K, Tada A, Nakada H, Mishima Y, Yoshimoto S, Matsuyama T, Kibata M, Nagare J.
    Kekkaku; 1991 Jun; 66(6):429-31. PubMed ID: 1942726
    [Abstract] [Full Text] [Related]

  • 31. [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections].
    Kawahara S, Nagare H.
    Kekkaku; 1998 Feb; 73(2):77-82. PubMed ID: 9545700
    [Abstract] [Full Text] [Related]

  • 32. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
    Piersimoni C, Morbiducci V, Bornigia S, De Sio G, Scalise G.
    Am Rev Respir Dis; 1992 Dec; 146(6):1445-7. PubMed ID: 1333738
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
    Vacher S, Pellegrin JL, Leblanc F, Fourche J, Maugein J.
    J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
    [Abstract] [Full Text] [Related]

  • 36. [Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook 7H10 media].
    Yamane N, Chilima BZ, Tosaka M, Okazawa Y, Tanno K.
    Kekkaku; 1996 Aug; 71(8):453-8. PubMed ID: 8831190
    [Abstract] [Full Text] [Related]

  • 37. [In vitro activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis].
    Sato K, Tomioka H, Saito H, Kawahara S, Hidaka T.
    Kekkaku; 1996 Aug; 71(8):459-64. PubMed ID: 8831191
    [Abstract] [Full Text] [Related]

  • 38. In vitro drug susceptibility of Mycobacterium other than tubercle bacilli.
    Imwidthaya P, Komolpis P, Suthiravitayavaniz K, Rienthong S.
    J Med Assoc Thai; 1990 Aug; 73(8):438-42. PubMed ID: 2262746
    [Abstract] [Full Text] [Related]

  • 39. Antituberculosis agents. VII. Synthesis and in vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
    Foroumadi A, Soltani F, Asadipour A.
    Boll Chim Farm; 2003 Apr; 142(3):130-4. PubMed ID: 12806833
    [Abstract] [Full Text] [Related]

  • 40. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium].
    Ogawa K, Miwa T, Sasamoto M, Sasaki T, Tsuda M, Honda K, Furui H, Torii K, Takagi K.
    Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.